Trial Disclosure – Regulatory Updates & FAQs

Mar 5, 2016

The requirements for data disclosure in clinical trials are continuously evolving. Although the purpose is to ultimately make data transparency greater, the constant updates can make it hard to understand what the current regulations are and what are coming up. This leads to many questions, including what data submissions are requirement for certain trials? What are the implications of the new EU regulation and the US expanded rulemaking? How do these regulations impact the running of future clinical trials?

Watch this 30-minute on-demand webinar to:

  1. Get insights into the latest clinical trial disclosure regulatory updates
  2. Understand their impact
  3. Ask your own questions about trial disclosure
 [contact-form-7 id=”10062″ title=”Contact form for webinar”]
LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Alberto Cantor
ArisGlobal
+1 609-360-4042 | acantor@arisglobal.com